Patient’s safety is the most important part of any system and Worldwide movement for the improvement of patient safety is gaining momentum; hence the subject of drug safety becomes even more prominent in the present day scenario. In context of ASU; with increased use of drugs of these systems, the scope for adulteration, preparation of counterfeit drugs and development of formulations which do not have conceptual basis in these systems has increased. As demands grow for medicinal plants possibilities of using laboratory generated species are increasing.
Hence a mechanism is required which can put all these things properly. For this propose National Pharmacovigilance programme for Ayurveda, Sidha and Unani medicine is in place.
The programme is being coordinated by NPRC-ASU under the guidance of National Pharmacovigilance Consultative Committee for ASU drugs being constituted by Department of AYUSH, Ministry of Health and FW, Govt. of India......
http://ayurvedaconsultants.com/caseshow.aspx?ivalue=engoogle2019
Hence a mechanism is required which can put all these things properly. For this propose National Pharmacovigilance programme for Ayurveda, Sidha and Unani medicine is in place.
The programme is being coordinated by NPRC-ASU under the guidance of National Pharmacovigilance Consultative Committee for ASU drugs being constituted by Department of AYUSH, Ministry of Health and FW, Govt. of India......
http://ayurvedaconsultants.com/caseshow.aspx?ivalue=engoogle2019
No comments:
Post a Comment